Trial Profile
A STUDY TO EVALUATE THE EFFICACY OF CJH1 [CLR4001] IN THE TREATMENT OF PARKINSON'S DISEASE
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs CLR 4001 (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 31 Dec 2013 Status changed from recruiting to completed, as reported on the Clera website.
- 18 Sep 2012 New trial record